Advertisement

Oral Biology pp 447-459 | Cite as

Quantitative Real-Time Gene Profiling of Human Alveolar Osteoblasts

  • Dawn E. CoatesEmail author
  • Sobia Zafar
  • Trudy J. Milne
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1537)

Abstract

The use of quantitative real-time reverse transcriptase PCR (qRT2-PCR) for the identification of differentially regulated genes is a powerful technology. The protocol presented here uses qRT2-PCR gene arrays to investigate the regulation of 84 angiogenic related genes in human primary alveolar osteoblasts following treatment with the bisphosphonate, zoledronic acid (ZA), and geranylgeraniol (GGOH). GGOH has potential as a therapeutic agent for Bisphosphate-Related Osteonecrosis of the Jaw (BRONJ), a serious side-effect resulting from the treatment for metastatic cancer (Zafar et al., J Oral Pathol Med 43:711–721, 2014; Ruggiero, Ann NY Acad Sci 1218:38–46, 2011). The isolation of the primary osteoblast cells follows the methods previously described (Dillon et al., Methods Mol Biol 816:3–18, 2012) with a new RNA extraction technique described fully. The method highlights the importance of obtaining high-quality RNA which is DNA-free. Relative levels of gene expression are normalized against selected housekeeping genes (HKG) and a number of examples of how fold regulation (2−∆∆Cq) and gene expression level (2−∆Cq) data can be presented are given.

Key words

Quantitative real-time reverse transcriptase PCR (qRT2-PCR) Bisphosphonate-related osteonecrosis of the jaw (BRONJ) Zoledronic acid Geranylgeraniol PCR arrays 

References

  1. 1.
    Zafar S, Coates DE, Cullinan MP, Drummond BK, Milne T, Seymour GJ (2014) Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts. J Oral Pathol Med 43:711–721CrossRefPubMedGoogle Scholar
  2. 2.
    Ruggiero SL (2011) Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann NY Acad Sci 1218:38–46CrossRefPubMedGoogle Scholar
  3. 3.
    Dillon JP, Waring-Green VJ, Taylor AM, Wilson PJM, Birch M, Gartland A, Gallagher JA (2012) Primary human osteoblast cultures. Methods Mol Biol 816:3–18CrossRefPubMedGoogle Scholar
  4. 4.
    Chim SM, Tickner J, Chow ST, Kuek V, Guo B, Zhang G, Rosen V, Erber W, Xu J (2013) Angiogenic factors in bone local environment. Cytokine Growth Factor Rev 24:297–310CrossRefPubMedGoogle Scholar
  5. 5.
    Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, Nagashima M, Nakamura T (2003) Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32:491–501CrossRefPubMedGoogle Scholar
  6. 6.
    Ramasamy SK, Kusumbe AP, Wang L, Adams RH (2014) Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507:376–380CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Kusumbe AP, Ramasamy SK, Adams RH (2014) Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507:323–328CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Czekanska EM, Stoddart MJ, Ralphs JR, Richards RG, Hayes JS (2014) A phenotypic comparison of osteoblast cell lines versus human primary osteoblasts for biomaterials testing. J Biomed Mat Res 102:2636–2643CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  1. 1.Faculty of Dentistry, Sir John Walsh Research InstituteUniversity of OtagoDunedinNew Zealand

Personalised recommendations